Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: VOLUME

I've posted on this subject before. Because of the limitations placed on the use of losses after there is a mor ethan 50% change in ownership, any Crossflo losses would only be advantageous if Crossflo itself is profitable in the future. For all intents and purposes, the Crossflo losses would not substantially reduce the taxes due on Patriot net income because of limitations based on the transfer of ownership.

Share
New Message
Please login to post a reply